000			02228 a2200673 4500
005			20250515183304.0
264		0	_c20100426
008			201004s 0 0 eng d
022			_a1432-0428
024	7		_a10.1007/s00125-009-1484-7 _2doi
040			_aNLM _beng _cNLM
100	1		_ade Galan, B E
245	0	0	_aCognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. _h[electronic resource]
260			_bDiabetologia _cNov 2009
300			_a2328-2336 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAntihypertensive Agents _xtherapeutic use
650	0	4	_aCognition _xdrug effects
650	0	4	_aCognition Disorders _xcomplications
650	0	4	_aDiabetes Mellitus, Type 2 _xblood
650	0	4	_aDiabetic Angiopathies _xepidemiology
650	0	4	_aDrug Combinations
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEducational Status
650	0	4	_aFemale
650	0	4	_aGliclazide _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aHypoglycemia _xepidemiology
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aIndapamide _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMental Status Schedule
650	0	4	_aMyocardial Infarction _xepidemiology
650	0	4	_aPerindopril _xtherapeutic use
650	0	4	_aRisk Factors
650	0	4	_aStroke _xepidemiology
700	1		_aZoungas, S
700	1		_aChalmers, J
700	1		_aAnderson, C
700	1		_aDufouil, C
700	1		_aPillai, A
700	1		_aCooper, M
700	1		_aGrobbee, D E
700	1		_aHackett, M
700	1		_aHamet, P
700	1		_aHeller, S R
700	1		_aLisheng, L
700	1		_aMacMahon, S
700	1		_aMancia, G
700	1		_aNeal, B
700	1		_aPan, C Y
700	1		_aPatel, A
700	1		_aPoulter, N
700	1		_aTravert, F
700	1		_aWoodward, M
773	0		_tDiabetologia _gvol. 52 _gno. 11 _gp. 2328-2336
856	4	0	_uhttps://doi.org/10.1007/s00125-009-1484-7 _zAvailable from publisher's website
999			_c19091440 _d19091440